back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-04-29 16:06 Tx date 2025-03-13 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
$-47,500
-250,000 vol $0.19 each |
2,465,727 | |
| Filed 2025-04-29 16:00 Tx date 2016-12-21 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$262,500
+175,000 vol $1.50 each |
275,000 | |
| Filed 2025-04-29 15:19 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2025-04-29 15:02 Tx date 2018-11-29 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+175,000 vol |
939,480 | |
| Filed 2025-04-29 15:00 Tx date 2018-03-23 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+100,000 vol |
764,480 | |
| Filed 2025-04-29 14:58 Tx date 2018-11-29 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-175,000 vol |
0 | |
| Filed 2025-04-29 14:56 Tx date 2018-03-23 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-100,000 vol |
0 | |
| Filed 2025-04-29 14:51 Tx date 2016-12-28 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$876,720
+584,480 vol $1.50 each |
664,480 | |
| Filed 2025-03-27 11:50 Tx date 2018-11-29 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
97 - Other
|
+175,000 vol |
||
| Filed 2025-03-27 11:48 Tx date 2018-11-29 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
97 - Other
|
-175,000 vol |
||
| Filed 2025-03-27 11:46 Tx date 2018-03-23 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
97 - Other
|
+100,000 vol |
||
| Filed 2025-03-27 11:43 Tx date 2018-03-23 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
97 - Other
|
-100,000 vol |
||
| Filed 2025-03-27 11:37 Tx date 2016-12-28 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
97 - Other
|
$876,720
+584,480 vol $1.50 each |
||
| Filed 2017-01-03 13:05 Tx date 2016-12-28 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
97 - Other
|
$876,720
+584,480 vol $1.50 each |
||
| Filed 2016-12-23 14:30 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-23 14:24 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-27 11:56 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,465
+34,725 vol $0.071 each |
2,378,485 | |
| Filed 2025-03-27 11:55 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$298.55
+4,265 vol $0.07 each |
2,343,760 | |
| Filed 2025-03-27 11:55 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,733
+731,368 vol $0.068 each |
2,339,495 | |
| Filed 2025-03-27 11:54 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,556
+68,000 vol $0.067 each |
1,608,127 | |
| Filed 2025-03-27 11:53 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,045
+100,647 vol $0.07 each |
1,540,127 | |
| Filed 2025-03-27 11:52 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,000
+500,000 vol $0.064 each |
1,439,480 | |
| Filed 2025-03-27 11:50 Tx date 2018-11-29 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
97 - Other
|
+175,000 vol |
939,480 | |
| Filed 2025-03-27 11:48 Tx date 2018-11-29 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
97 - Other
|
-175,000 vol |
0 | |
| Filed 2025-03-27 11:46 Tx date 2018-03-23 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
97 - Other
|
+100,000 vol |
764,480 | |
| Filed 2025-03-27 11:43 Tx date 2018-03-23 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
97 - Other
|
-100,000 vol |
0 | |
| Filed 2025-03-27 11:37 Tx date 2016-12-28 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
97 - Other
|
$876,720
+584,480 vol $1.50 each |
664,480 | |
| Filed 2025-03-27 11:32 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,478
+1,300 vol $2.68 each |
181,000 | |
| Filed 2025-03-27 11:30 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,528
+1,700 vol $2.66 each |
179,700 | |
| Filed 2025-03-27 11:29 Tx date 2017-08-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,955
+5,000 vol $2.39 each |
178,000 | |
| Filed 2025-03-27 11:26 Tx date 2017-08-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,254
+5,000 vol $2.25 each |
173,000 | |
| Filed 2025-03-27 11:23 Tx date 2016-11-16 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,504
+8,800 vol $1.08 each |
168,000 | |
| Filed 2025-03-27 11:21 Tx date 2016-11-15 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$65,400
+60,000 vol $1.09 each |
159,200 | |
| Filed 2025-03-27 11:18 Tx date 2016-11-14 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,000
+10,000 vol $1.10 each |
99,200 | |
| Filed 2025-03-27 11:17 Tx date 2016-11-11 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,920
+27,200 vol $1.10 each |
89,200 | |
| Filed 2025-03-27 11:14 Tx date 2016-11-09 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,500
+25,000 vol $1.10 each |
62,000 | |
| Filed 2025-03-27 11:11 Tx date 2016-10-27 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,520
+19,000 vol $1.08 each |
37,000 | |
| Filed 2025-03-27 11:08 Tx date 2016-10-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+10,000 vol $1.05 each |
18,000 | |
| Filed 2025-03-27 11:04 Tx date 2016-10-18 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,320
+8,000 vol $1.04 each |
8,000 | |
| Filed 2025-03-27 11:01 Tx date 2016-04-21 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-27 10:57 Tx date 2016-04-21 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
80,000 | ||
| Filed 2025-03-27 10:52 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-13 13:16 Tx date 2016-11-16 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,504
+8,800 vol $1.08 each |
||
| Filed 2018-08-13 13:14 Tx date 2016-11-15 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$65,400
+60,000 vol $1.09 each |
||
| Filed 2018-08-13 13:13 Tx date 2016-11-14 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,000
+10,000 vol $1.10 each |
||
| Filed 2018-08-13 13:11 Tx date 2016-11-11 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,920
+27,200 vol $1.10 each |
||
| Filed 2018-08-13 13:10 Tx date 2016-11-09 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,500
+25,000 vol $1.10 each |
||
| Filed 2018-08-13 13:08 Tx date 2016-10-27 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,520
+19,000 vol $1.08 each |
||
| Filed 2018-08-13 13:06 Tx date 2016-10-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+10,000 vol $1.05 each |
||
| Filed 2018-04-17 12:44 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,478
+1,300 vol $2.68 each |
||
| Filed 2018-04-17 12:43 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,528
+1,700 vol $2.66 each |
||
| Filed 2018-04-17 12:40 Tx date 2017-08-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,955
+5,000 vol $2.39 each |
||
| Filed 2018-04-17 12:38 Tx date 2017-08-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,254
+5,000 vol $2.25 each |
||
| Filed 2017-09-01 12:47 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,808
+1,300 vol $2.16 each |
||
| Filed 2017-09-01 12:46 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,655
+1,700 vol $2.15 each |
||
| Filed 2017-09-01 12:44 Tx date 2017-08-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,650
+5,000 vol $1.93 each |
||
| Filed 2017-09-01 12:42 Tx date 2017-08-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,150
+5,000 vol $1.83 each |
||
| Filed 2017-01-03 13:05 Tx date 2016-12-28 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
97 - Other
|
$876,720
+584,480 vol $1.50 each |
||
| Filed 2016-04-27 16:04 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-12-13 19:14 Tx date 2022-12-09 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$278,488
+1,465,727 vol $0.19 each |
2,615,727 | |
| Filed 2021-05-14 18:47 Tx date 2021-05-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,150,000 | |
| Filed 2021-02-08 10:10 Tx date 2021-01-10 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
$-532,000
-350,000 vol $1.52 each |
150,000 | |
| Filed 2020-03-14 11:30 Tx date 2020-03-13 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$47,500
+250,000 vol $0.19 each |
500,000 | |
| Filed 2019-01-14 Tx date 2019-01-10 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$532,000
+350,000 vol $1.52 each |
250,000 | |
| Filed 2018-12-24 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
||
| Filed 2018-12-24 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
||
| Filed 2018-12-20 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
||
| Filed 2018-12-20 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
||
| Filed 2018-12-20 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
175,000 | |
| Filed 2018-12-20 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
275,000 | |
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
837,480 | |
| Filed 2018-12-15 Tx date 2018-11-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$262,500
+175,000 vol $1.50 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
937,480 | |
| Filed 2018-12-15 Tx date 2018-11-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$262,500
+175,000 vol $1.50 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
||
| Filed 2018-12-15 Tx date 2018-11-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$262,500
+175,000 vol $1.50 each |
1,012,480 | |
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
||
| Filed 2018-12-15 Tx date 2018-11-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$262,500
+175,000 vol $1.50 each |
1,012,480 | |
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
||
| Filed 2018-12-15 Tx date 2018-11-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$262,500
+175,000 vol $1.50 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
837,480 | |
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$20,000
+100,000 vol $0.20 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
937,480 | |
| Filed 2018-12-15 Tx date 2018-11-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$262,500
+175,000 vol $1.50 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$20,000
+100,000 vol $0.20 each |
||
| Filed 2018-12-07 Tx date 2018-11-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$-262,500
-175,000 vol $1.50 each |
175,000 | |
| Filed 2018-12-07 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
175,000 | |
| Filed 2018-11-30 Tx date 2018-11-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$262,500
+175,000 vol $1.50 each |
450,000 | |
| Filed 2018-08-13 Tx date 2016-11-15 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$65,400
+60,000 vol $1.09 each |
231,200 | |
| Filed 2018-08-13 Tx date 2016-11-16 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,504
+8,800 vol $1.08 each |
240,000 | |
| Filed 2018-08-13 Tx date 2016-11-14 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,000
+10,000 vol $1.10 each |
171,200 | |
| Filed 2018-08-13 Tx date 2016-11-11 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,920
+27,200 vol $1.10 each |
161,200 | |
| Filed 2018-08-13 Tx date 2016-11-09 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,500
+25,000 vol $1.10 each |
134,000 | |
| Filed 2018-08-13 Tx date 2016-10-27 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,520
+19,000 vol $1.08 each |
109,000 | |
| Filed 2018-08-13 Tx date 2016-10-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+10,000 vol $1.05 each |
90,000 | |
| Filed 2018-04-17 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,478
+1,300 vol $2.68 each |
677,480 | |
| Filed 2018-04-17 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$20,000
+100,000 vol $0.20 each |
||
| Filed 2018-04-17 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,528
+1,700 vol $2.66 each |
676,180 | |
| Filed 2018-04-17 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
275,000 | |
| Filed 2018-04-17 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,655
+1,700 vol $2.15 each |
||
| Filed 2018-04-17 Tx date 2017-08-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,955
+5,000 vol $2.39 each |
674,480 | |
| Filed 2018-04-17 Tx date 2017-08-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,650
+5,000 vol $1.93 each |
||
| Filed 2018-04-17 Tx date 2017-08-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,254
+5,000 vol $2.25 each |
669,480 | |
| Filed 2018-04-17 Tx date 2017-08-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,150
+5,000 vol $1.83 each |
||
| Filed 2018-04-17 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,808
+1,300 vol $2.16 each |
||
| Filed 2018-03-27 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$20,000
+100,000 vol $0.20 each |
275,000 | |
| Filed 2017-09-01 Tx date 2017-08-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,650
+5,000 vol $1.93 each |
674,480 | |
| Filed 2017-09-01 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,808
+1,300 vol $2.16 each |
677,480 | |
| Filed 2017-09-01 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,655
+1,700 vol $2.15 each |
676,180 | |
| Filed 2017-09-01 Tx date 2017-08-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,150
+5,000 vol $1.83 each |
669,480 | |
| Filed 2017-01-03 Tx date 2016-12-28 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
97 - Other
|
$876,720
+584,480 vol $1.50 each |
664,480 | |
| Filed 2016-12-23 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
175,000 | ||
| Filed 2016-12-23 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-05 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Rowe Family GST (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
11,120,000 | ||
| Filed 2016-05-05 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Rowe Family GST (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-27 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-27 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-27 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
80,000 | ||
| Filed 2016-04-27 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Rowe Family GST (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,112,000 |